Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Roche Holding AG (OTCQX International Premier:RHHVF)

256.25
Delayed Data
As of 3:44pm ET
 +3.10 / +1.22%
Today’s Change
238.95
Today|||52-Week Range
302.43
-6.50%
Year-to-Date
Roche's Multiple Sclerosis Drug Under Review by FDA, EMA
4:02pm / Zacks.com - Paid Partner Content
Brexit Sell-Off Hits 3 Big Pharma Bargain Stocks
Jun 24 / MotleyFool.com - Paid Partner Content
Instead of Panicking on Brexit, Buy These Stocks
Jun 28 / TheStreet.com - Paid Partner Content
Epizyme Teams Up with Roche's Genentech for Tazemetostat
Jun 23 / Zacks.com - Paid Partner Content
Puma (PBYI) Submits Neratinib Marketing Application in EU
Jun 28 / Zacks.com - Paid Partner Content
1 Stock to Invest in Big Pharma
Jun 19 / MotleyFool.com - Paid Partner Content
The 5 Best Healthcare ETFs
Jun 26 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close253.15
Today’s open257.00
Day’s range256.25 - 258.80
Volume8,756
Average volume (3 months)4,860
Market cap$177.9B
Dividend yield3.31%
Data as of 3:44pm ET, 06/29/2016

Growth & Valuation

Earnings growth (last year)-9.95%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-3.56%
P/E ratio--
Price/Sales4.76
Price/Book10.29

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$50.0B
Annual profit (last year)$9.2B
Net profit margin18.41%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Severin Schwan
COO-
Roche Diagnostics Division
Roland Diggelmann
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts

Partner Offers

Search for Jobs